Introduction
Positron emission tomography (PET) and single photon emission computed tomography (SPECT) have made possible the in vivo investigation of neuroreceptors, transportersand enzymes that are implicated in disease statessuch as schizophrenia, Parkinson's disease as well as in addiction and processes associated with aging. Some of the tracersused and the receptorshransportersthatthey label are: [1lC]raclopride (Farde et al. 1989; Volkow et al. 1993; Hietala et al. 1999) , [1*C]N-methylspiperone (Wong et al. 1986a (Wong et al. ,1986b , [1231] epidepride for the D2 dopamine receptor; [1lC]-Schering 23390 (Farde et al. 1987; Suharaet al 1991) , [1*C]NNC 112 (Abi-Dargham et al. 2000) , for the D1 receptor; [1lC]benztropine (Dewey et al. 1993a) , scopolamine (Frey et al. 1992) , [llC] tropanyl benzilate (Koeppe et al. 1994) , [llC] NMPB (Zubieta et al. 1998) , [lgF] FP-TZTP, for the muscarinic cholinergic system; [1lC] cocaine (l?owler et al. 1989) [1lC]d-threo methlyphenidate Ding et al. 1994 Ding et al. , 1997 , for the dopamine transporter;[1lC]dihydrotetrabenazine (Koeppe et al. 1995) , for the vesicular monoamine transporter;[1lC]carfentanil (Frost et al. 1989) for the opiate receptor; [11C]WAY-100635 (Mathis et al.1994; Farde et al.1998) , for the 5HT1A; [llC] flurnazenil (price et al. 1993 ) and [12311 iomazenil (Bremner et al. 2000) for the benzodiazepine receptor. Examples of ligands used for the study of brain enzymes are [llC] Ldeprenyl and [*lC]L-deprenyl-D2 (MAO B) (Fowler et al. 1987 , [llC] clorgyline (MAO A) (Fowler et al. 1987) , and [llC] PMP (acetylcholinesterase) (Koeppe et al. 1999 ).
Jnorder to allow comparisons between subjects of measures related to receptor concentration, it is necessary to separatephysiological process related to receptor concentration from other processes thatinfluence tracer uptake. In order to do this many methods of varying complexity have been developed and applied. Many a-e based on one or two tissue compartment models in which uptake into tissue is driven by the plasma concentration of the labelled tracer. The measurementsare radioactivity concentration in tissue (PET/SPECT) and plasma radioactivity y which is divided into that due to unchanged tracer and its metabolizes. In some cases these have been simplified so that a reference region (a region of interest(ROI) from the PET study thatis devoid of the receptor/transporterbeing studied) is used in place of an input fimction. Also some techniques don't require fill dynamic scanning relying on an equilibrium between tissue and blood. is actually a multistep process. Due to the fact thatonly the total tissue radioactivity can be measured and not its components, the number of identifiable model parametersis limitedgenerally to no more than 4, if that.
While there are techniques for separatelyevaluatingreceptor number and affinity, these experiments are difficult and require the administrationof a sufficient amount of drug to block a substantialfraction of receptors. While these studies have the potential for providing important information they will not be discussed here. Most PET/SPECT experiments, particularlyin a clinical setting, are in the high specific activity range and the model parametersfor reversibly binding ligands are some measure of Bmax'/Kd where Bmax' is taken to be the fi-eereceptor concentration and Kd is the receptor-ligand equilibrium dissociation constant.
When the free receptor/enzyme concentration does not change over the course of the experiment, the model equations are first order linear differential equations which can be solved eithernumerically or in closed form. Even if the receptor concentration is changing due to a change in neurotransmitterconcentration fi-oma drug treatment,these equations can still be solved in the same way but the model parameterrelated to Bmax' represents some average over the course of the experiment. There area number of approaches thathave been used to evaluatethe model parameters. These range from the most complex -optimizing model parametersby solving the model differential equations, a nonlinear least squares approach (NLLSQ), to a ratio of tissue activity in an equilibrium measurement. There are a number of modifications thathave been applied to the set of differential equations that simpli@ the modeling process and in some . .
cases eliminate the necessity of measuring an arterialinput fiction. A review of various modeling techniques and their strengthsand weaknesses is the subject of this chapter.
Models
General models for the description of tracerdistributionand binding are given below binding, kqrepresents (saturable)binding to specific receptor/transportersand h is the receptorligand dissociation constant. A simplification of models I and II is thatthe constants describing nonspecific binding (kNs'and kNs") are sufficiently greaterthanthe other kinetic constantsthat the concentration of flee ligand is a constant fi-actionof the total (free plus nonspecifically bound), thatis C~fNs CT where fNsis the flee fkaction (Mi.ntunet al. 1984) . With this assumption the models become
Model Ib
However, it has been found in a number of cases thatit is necessary to use 2 tissue compartments . to described the cerebellum (reference region) (for example Abi-Dargham et al. 2000 , Logan et al. 1991 ) so thatthe nonspecific consists of two parts -one rapid and one slower with binding constants k5 and kb There is the question of whether or not this additional binding is also present in the receptor containing region. In fact, Seeman et al (1990) reported thatnonspecific binding of raclopride is greaterin the basal ganglia than in cerebellum.
In some cases the binding is irreversible on the time scale of the~xperirnentso thatthe model becomes The transportconstants K1 (plasma to tissue) and kz (tissue to plasma) are fictions of blood flow and the permeability surface areaproduct, PS. Based on a homogeneous single capillary model in which tissue concentration surroundingthe capillary is constant over the time of capillary transit,the transportconstants can be related to F and PS as (Crone, 1963; Renkin, 1959; Kety 1951; Patlak and Fenstermacher1975) "
More complex models relating tracertransportand flow have been considered by Sawada et al. (1991) . The distinction between PSI and PSZinvolves the inco~oration of the free fraction in plasma and tissue, that is PS1=PS@ where @is the free fraction of ligand in plasma and p&=pSfNs with fNsbeing the free fraction in tissue. The use of @ and fNspresumes that equilibrium between fi-eeand bound ligand is rapidly achieved on a time scale shorterthanthe capillary transittime. The unbound ligand is assumed to pass through the blood brain-barrierby passive diffkion.
The differential equations of Model IIb, the commonly used model for receptor binding, are given by
The assumption implicit in the model of specific binding is thatthe receptor occupancy is unchanged during the course of the experiment. The parameterk3 is given by kg=~NskO@max-NB-L) where Bmax is the total receptorhmnsporterconcentration and NB is the endogenous neurotransmitterconcentration. L is the concentration of unlabeled ligand bound to receptors.
In the high specific activity limit L is negligible compared to Bmax and is neglected. On the other hand NB is generally not negligible and can influence the amount of tracer thatbinds to receptors and hence the measure of receptor availability. How NB affects the number of binding sites available to the tracer ligand depends upon several factors. If NE and the labelled tracer (L*) both bind to the same site or to overlapping sites on the receptor, then L* will reflect the reduced number of sites. If they don't bind to the same site, then L* will reflect more the total number of sites, although if it doesn't bind to the fictional site, it may not necessarily be a good measure of a fictional receptor.
In many PET studies drag induced neurotransmitterchanges are monitored with tracer ligands. Neurotransmittercompetition with labelled tracershas been studied by Dewey et al. .. (1990 Dewey et al. .. ( , 1993a Dewey et al. .. ( , 1993b Dewey et al. .. ( ), his et al. (1992 , Volkow et al. (1994) , Laruelle et al. (1997) and others.
In these cases NE is changing with time (NB(t)). Although the model equations areno longer linear, they can be solved as though they were by assuming a "constant" Bmax'=Bmax-NB.
Endres and (Inoue et al. 1999a ). Inoue et al. (1999b) offer evidence thatthese ligands bind to different sites on the receptor. Furthermorethe receptors appear to form dimers and larger clusters. Differences in the binding properties maybe due to the different binding capacities to D2 receptor dirnersand monomers. Zawarynski et al. (1998) found that a spiperone derivative labelled only the D2 monomer and a raclopride derivative both the dimer and the monomer. These results and others relating to the occupancy model are discussed by Laruelle (2000) . In any case,.for many ligands the models described . . above provide a usefid tool for comparing data althoughthey are certainly an approximation to the underlying physiological processes.
Strategies for determining model parameters

Measures of receptor availability
Rather than compare individual model parameterswhich are subject to considerable variability (Carson et al. 1993) , comparison among subjects is usually made by comparing a composite parameterthatis a combination of model parameters. For reversible ligands this is eitherthe binding potential (BP) (Min~,et al. 1984) , the total tissue distributionvolume (DV), the distributionvolume ratio (DVR) (the ratio of the DV of a receptor region to thatof a reference region without the receptor) or an effective binding potential derived born the DVR.
Another possibility is the difference between the receptor DV (DVRO1)and the DV of the reference region (DVmF). All of these measures are a function of the free receptor binding sites but they each depend upon assumptions about the constancy of other processes. The binding potential is defined as BP =Bmax'/Kd (Mintun et al. 1984) . In terms of the model parameters used here it is given by kq/(k&Ns) since k3 implicitly contains the free fraction (fNs) (kq=kO~Bmax' al. 1984 ,~NS=fiO) M~Y resemchers 'efie the btiding potential as BP=k3/k4 =Bmax' /Kd' where Kd' i.UChJdeS~Ns "(Kd'=kof~(konfh) 'Kd/fNs). h ttis case, the assumption is that~Nsis constant and does not contribute to differences in BP.
The distributionvolume is given by the ratio of the tissue to plasma under equilibrium conditions, thatis DV=CRol/Cp, CRO1 is the tissue concentration of a region of interest. For some ligands equilibrium can be achieved and the DV can be measured in this manner (see below).
Alternatively, the DV given by (Lassen and Perl, 1979) as ]Gx(w
is valid for nonequilibrium experimental conditions. In most cases this is not a practical approach to calculating the DV. The DV can be determined under nonequilibrium conditions directly by graphical analysisdescribed below. The DV can also be determined fi-omthe model
parameterswhich for the 1 and 2 tissue compartment models (Model Ib and Model (Lib)) are K1/k2and K1/k2(l+k3/l@, respectively. If there is a component of slow nonspecific binding in both, then these become K1/k2(l+k3&+k5/kG) and K1/k2(l+k&).
Since the transportconstants are a fimction of plasma protein binding (PS1=PS@ in Eq(l)), the DV also depends upon plasma protein binding. This can be eliminatedby independently measuringfi and removing it fi-omthe DV (DV/fi) (Carson et al. 1993 ). The problem is thatgenerally a large fraction of ligand is bound to plasma proteins so that errorsin the determinationoffi can introduce considerable variability into the DV. By basing comparisons on the distributionvolume ratio (DVR) the dependence upon plasma protein binding is removed. The DV'S can be determined directly by graphical analysis or equilibrium measurementfor example. The DVR is then (assuming thatthe ratio of transportconstants is the same for both receptor and reference region)
The BP can then be calculated indirectly as DVR-1 as opposed to explicitly determining k3 and 
where k5 Subtractingthe reference DV from the ROI DV gives K1/k2(BP) defining BP as k3/k4. This measure is dependent uponfi throughK1 but the dependence uponfNs has been removed since it appears in both kz and k3 and therefore c~cels (see Carson et al. 1997) . A comparison of
outcome measures for equilibrium, kinetic and graphical methods is given by Laruelle (2000) (see Table 6 in that article).
For irreversibly binding ligands, receptor availability is contained in model parameterks. Logan et al. (2000a) found thatreproducibility on testlretestfor [llC] L-deprenyl-D2 significantly improved if comparison is based on the combination parameterlk3 where A=K1/k2. Graphical analysis (Patlak et al. 1983 ) of uptake data from irreversible ligands provides an influx constant Ki given by K1k3/(k2+ k3) which depends upon blood flow (see below).
Modeling Options for Reversible Ligands With a measured plasma input function
The model parameterscan be optimized by solving the differential equations using a measured plasma input fimction and determining g the set of values that give the best fit to the data. For a discussion of optimization methods see Carson (1986) . The BP and DV can then be 
A more general approach tolinear least squares analysis is given by Thie et al (1997) .
This approach is model independent in thatthe constants can be determined without reference to a particularmodel. There are 2n coefficients Ci in which fits to data can be made with n=l,2 or 3 and the optimum number selected based on a statisticalanalyses (Thie et al. 1997 )
The problem is thatthe coefficients are function of both blood flow and the receptor parameter.
Parameterestimatesbased on the linear forms of the model equations as in Eq (5) are subject to bias because the equation errors, are not statisticallyindependent thatis each succeeding one depends upon the previous one (Feng et al. 1993 (Feng et al. , 1996 . In order to overcome the bias problem, Feng et al. (1993) introduced a generalized linear least squares (GLLS) method which removes the bias. The GLLS form of the one tissue model is Feng et al have generalized this to more complex models (Feng et al. 1996) .
In graphical analysis the set of linear equations describing a general model is transformed into a single equation which becomes linear for time t> t* (Logan et al. 1990 ). While this is applicable to a multicompartmentsystem, only two parametersare determined, the slope and the interceptwhich are combinations of the model parameters.The graphical analysis equation for points determined by scan times ti is
where DV+Vp is the slope for the linear region which occurs for times ti>t*and Vp is the contribution of the tissue blood volume. The condition for linearity of Eq (7) is thatthe intercept (int) which for a two tissue compartment model is given by
is constant. For some time t > t',the compartment concentrations follow the plasma concentration so that (Cl +C2) cc Cp and C2CC Cp (the steady state condition) which insures that -"intis constant since Cp cancels. In many cases the interceptbecomes constant even before, (C1+C4/Cp becomes constant. Therefore the graphicalmethod can be applied before the steady statecondition becomes valid, when for some time t* < t~the ratio C2/(Cl+C2) varies slowly and is effectively constant. The limiting value of the time dependent portion of the intercept is given by
C2(t)~1
The graphical analysis is illustratedin The graphical method has been extended by Ichise et al. (1999) to account for labelled lipophilic metabolizes which could cross the blood-brain barrier, interferingwith the quantification of ligand uptake.
Alternatively the DV can be obtained directly by manipulatingthe plasma levels so that equilibrium is reached. Patlak and Petigrew (1976) developed a method for obtaining infision schedules to achieve specified blood concentration levels over time. This method has been used in particularto produce a constant input function. Carson et al. (1993) extended this method to include a bolus injection with a continuous infhsion to produce a true equilibrium so thatthe true DV is given by the ratio of tissue to plasma. The advantageis that only a few scans are required and arterialblood sampling is not necessary. Whether this method is appropriatedepends upon the kinetics of the tracer. A transientequilibrium between tissue (CT) and plasma can be achieved after a bolus injection so thatCT(t)/Cp(t) is constant. This however is generally not the true distributionvolume but is a fimction of the rate of plasma clearance (Carson et al. 1993; Logan et al. 1990 ).
Without a measured plasma input function
There are several approaches to determiningmodel parameterswithout an input fimction.
These methods require a reference region, a region devoid of the receptor/transporteror other binding site being studied. Lammertsma et al. (1996) presented a reference region method assuming the reference region could be described by a one tissue compartment model. They derived the following relationship between concentration of tracer in the reference region, CREF and CT,the total tissue concentration for a two compartmentmodel
where RI is the ratio K1 / KIMF, and a, b, c,and d are combinations of the model parameters,k2,k3, and k4 and are determined by standardnonlinear regression analysis. A simplified reference tissue model which assumes thatthe receptor region can also be described by a one tissue compartment is given by the equation (Lamertsma and Hume, 1996) 
CT (t)= RICWF (t) + [k, -R1k2
in which threeparameters,k2, RI and BP, are to be determined using nonlinear analysis. Gunn et al. (1997) revised this method so thattwo parametersRI and~are determined using a linear least squares optimization for a set of values of y C,(t) = RICmF (t) i-~CMF (t) @ exp(-yt) y and~are composite parameterscorresponding to Eq(9).
An alternativelinearization of the simplified reference tissue method was given by Logan et al. (2001 a) as
This method is based on the generalized linear least squaresmethod of Feng et al, (1993) . There are three constants to be determinedby a linear solution, k2, K1 / KIMF, and (K1 /K1wF ) (k, -k2mF) given an initial estimate,~,. Generally only a few iterationsare required (Feng et al. 1993 ).
Another method based on a reference region input is a modification of the graphical analysis method (Logan et al. 1996) . The DVR can be calculated directly with the graphical method by using data from a reference region (C~F (l)) with an average tissue to plasma efflux constant, Icz 
is small and/or reasonably constant the term containing k2 C,o, (T) can be neglected.
Ichise has proposed an alternativeto Eq(l 1) which is a multilineal regression (Ichise et al. 1996) . This method appears to provide the same results as Eq(l 1) with~Z 'CO. When lipophilic metabolizes are present in tissue, Ichise has proposed a method requiring a single blood sample generatethe DV from the DVR calculated using the reference tissue with the contaminating metabolizes .
to Farde et al. (1986 Farde et al. ( , 1989 
Modeling options for irreversible Iigands
With a measured plasma Input function
Irreversibly binding ligands (Model IIIb) are essentiallytrapped for the time course of the scanning procedure. Information about receptor availability is contained in model parameterks.
The three model parameterscan be estimatedusing an optimization procedure and solving the differential equations directly. Different approaches to optimizing k3 are illustratedin Koeppe et al. (1999) for the ligand [1lC]PMP which binds irreversiblyto acetylcholinesterase. These included unconstrained estimation of all threeparametersand constrained estimation of ks by fixing the K1/k2 ratio. This assumes thatthe ratio is relatively constant across the brain, an assumption which has been found to hold for a number of PET tracers. Alternatively, a model independent graphical method (Blasberg et al. 1979; Gjedde 1981; and Patlak et al.1983; Patlak and Blasberg 1985) parameters,K1 which representsthe transportof ligand from plasma to tissue and the combination parameterAk3 which also contains the ratio of transportconstants (2=K1/k2).
Although K1 and k2 are functions of blood flow, 2 is not. From Eq(5) it can be seen thatKi depends upon K1 (blood flow) as well as bee receptor/enzyme concentration (contained in Ak3). 
Only if k2 >> k3 so thatKi +Ak3, is Ki
V(T) = [1 C,O1(T)~k, '2~qT) +=(1+ P) Cp(T) k2 + k, k,m' k, () k :k '(l
-e-e(T) /t)
23
where p = k5& accounts,for a reversible component of either low specific or nonspecific binding in the receptor region. In the case of NMSP there are reference regions such as the cerebellum
K,MF without specific binding from which 2.=-kzm' is determined (when V(T) =CMF(T)/Cp(T)). The transitionof V(T) w O(T) to a linearphase at latertimes is determinedby~. When A is known
the model has three parameters,k2, k3 and p. It is assumed that p is not present in the reference region.
Without plasma input
When the concentration of original tracerin plasma reaches zero during the time of the study, k3 maybe estimated entirely from the shape of the time activity curve (TAC) (Frey et al. 1997a,b) . This method was applied to estimation of acteylcholinesterase activity and was found to be suitable for regions of low enzyme activity (Koeppe et al. 1999 ). Patlak and Blasberg (1985) extended the graphical analysis for irreversible ligands to an analysis using a reference region in place of the plasma input. It is assumed thatthe reference region has no specific binding so thatin the steady statecondition CmF 
Limitations, reliability and other factors related to modeling image data
Sensitivity of the outcome measure
The outcome measure must be sufficiently sensitive to variations in the underlying receptor availability to accurately register changes. This translatesinto particularrequirements of tracer ligand kinetics. In the case of reversibly binding ligands, the binding potential (k3/k4) needs to b.e sufficiently greaterthan one so thatit can be reliably estimated. If it is too small there will be little difference between the reference region with no receptor concentration DV=K1/k2 and the region with a receptor density DV= K1/k2 (l+k3/k4). On the other hand if BP is too large, it may become difficult to obtain an estimate of the DV in the time span of the experiment. In particular,if ks>> kz eitherdue to a hi@ affinity (kJ or a large Bmax or slow tissue to plasma efflux, then the concentration of ligand bound to receptor is limited by tracer delivery, a situation referred to as "flow limited". This leads to an underestimationof the DV (or a large uncertainty in the DV) or if using an irreversible model, the receptor parameterk3 is contaminated by delivery effects (see discussion in Koeppe et al. 1994) . This has been a problem for some of the muscarinic cholinergic ligands such as scopolamine (Frey et al. 1992 ) and less of a problem although still present for [1lC]tropanyl benzilate (Koeppe et al. 1994 ) and [1lC]benztropine (Dewey et al. 1993a) . . When K1 -Ki, only one parametercan be determined, KI, and no information can be obtained about enzyme/receptor concentration.). In the regions of higher specific binding the estimates of k3 become much more variable, althoughthey are highly correlated to k2 (Logan et al. 2000a; Koeppe et al. 1999) . In order to reduce this variability, Fowler et al. (1995) have used the parameterAk3 which is much more stable since it contains the ratio k3/k2. Alternatively Koeppe et al. (1999) proposed using a scheme in which all threeparameters are determinedbut the ratio %k3is scaled to the value of ii determined from a region of low specific binding thus giving a scaled value of k3.
The sensitivity of irreversible ligands that are close to the flow limit can be improved by reducing the binding parameter,k3. This was done with the tracer [1lC]L-deprenyl by substitutingdeuteriumfor hydrogen at the reaction site. This is an example of the kinetic isotope effect in which the increased mass of the atom involved in the reaction slows the reaction rate. sensitivity of H2 to differences in MAO B concentration is much less than for the D2 Iigand, This leads to greatervariability in model parameters.
Which Model?
The model structurethatbest describes a data set is not necessarily driven by the presence of multiple types of binding. For example, a ROI from a receptor containing region could be described by a one tissue compartment model even though there is specific binding to the receptor as well as nonspecific binding. Why the binding kinetics of one ligand requires a twocompartment model while the kinetics of anotherdoes not has to do with the impulse response fimction of the two-compartment model given by
Al exp(-alt) i-Az exp(-azt) ) where A1,2and a1,2 are combinations of K1,k2,k3 and k4. If one of the exponential terms dominate, then a one compartment model will adequately describe the data. Following ) whether a two compartment fit is required can be determinedby considering the fraction of the area of the response function due to the second term for time T, that is
The effect of varying the binding parametersk3 and k4 (while maintaininga constant binding potential, ks/k4) on the integratedresponse fimction ratio of Eq 14 is shown in Figure 4 . Using model parameterssimilar to those found for [1lC]raclopride with Kl=. 15 and k2=.36 for all simulations giving DV = 1.917 (DVl indicates the DV generatedby fitting the data to a one tissue compartment model with two parameters,DV2 a two tissue model with four parameters).
The maximum time was 60 min. DV1 underestimatesthe trueDV for the lower values of k3 and k4. This is improved somewhat by extending the analysis time to 95 min for which DV1 becomes 1.59 for k3=0.09. The graphical DV'S for the 4 cases were 1.80, 1.89, 1.92, 1.92. Extending the time to 95 min the DVG was found to be 1.89 and 1.91 for k3=0.09 and 0.18 rein-l respectively.
There was no change in the other two. For the simulationswith k3=0.09 and 0.18 a two compartment model is required to recover the true DV using the NLLSQ method. For the two simulations with higher values of k3 and k4, DV1 is close to the true DV and the addition of anothertissue compartment would not be justified since the parameterswould most likely not be identifiable in the presence of noise.
There are also instances in which the "nonspecific" reference regions are better described by a two tissue compartmentmodel. This has been observed for some studies with the radioligands [llC] raclopride (for example Logan, 2001b) , and [18F]spiperone (Logan et al.1987) . Also AbiDargham et al. (2000) observed that a two compartmentmodel gave a somewhat better fit to cerebella data for the D1 ligand [1lC]NNC 112. From 16 studies in the baboon with [llC] raclopride the DVI underestimatedthe DV compared to DVZ and to DV~, DV1/DV2=.83&.05 and DVG/DV2=.98+.02 (Logan et al. 2001b ). This appears not to be related to specific binding. This apparentadditional binding could be due to an error in the metabolize correction of the input fimction. If the fi-actionof original traceris small at later times, then a small error in the metabolize correction will resultin a large difference in the plasma concentration . Also uptake of a small quantity of lipophilic metabolizes at latertimes will result in a bias in the model. Whether the second compartment in these nonspecific regions is due to this or is in fact a true slow nonspecific binding is unclear. Also anotherissue is whether it is also present in the ROI under study and should be taken into account. An alternativereference tissue model is used by Acton et al. (1999) for describing
Reference tissue methods
Sossi
[99mTc]TRODAT-1 binding to DA transportersin baboons using SPECT. The assumptions made were thatthe transportconstants were the same in both the ROI and reference region and thatthe specific binding component could be extractedby subtractingthe reference region from the ROI as in Farde's pseudoequilibrium method. The constraintof having the same transportparameters for both regions is not likely to be valid for all ligands limiting the usefulness of this technique.
The reference region method was lower thanthe BP derived using the compartment model but the same constraintwas used in the model. Also it is unlikely thatthe specifically bound is accurately representedby the difference between the ROI and reference region over the time course of the study. .
Bias in the Graphical Analysis Method
The graphical analysis method is a usefid tool for rapidly obtaining information about the binding of radioligands. The strengthof the method is thatit does not require a particularmodel structure. However, since it is derived from the linearized compartmental equations, it also displays a bias in the case of noisy data resultingin the underestimationof the slope (DV) and the underestimationis greaterwith larger DV'S (Hsu et al. 1997; Slifstein et al. 1999; AbiDargham et al. 2000) . In order to remove the bias, Logan et al. (2001a) have proposed a modification of the GLLS method developed by Feng et al. (1993) to use as a smoothing technique for more general classes of model structures. The one compartment GLLS method was applied to the data in two parts, thatis one set of parameterswas determined for times Oto T1and a second set from T'l to the end time. The curve generated fi-om these two sets of parameterswas then used as input to the graphical method. This was been tested using simulations of data similar to that of the PET ligand [1lC]-d-threo-methylphenidate (MI?, DV=35. mL/m.L) and [llC] raclopride (RAC, DV=l .92 mL/mL) with the result thatin the case of moderate noise the bias was substantiallyremoved. This combination of the GLLS method and ,. the graphical method provides the possibility of retainingthe model independent type of analysis without the bias inherentin the linearmethods while still maintaining a fairly simple method of analysis. This method was also applied to the simplified reference tissue model of Lammertsma and Hume (1996) . The equation was modified to allow a linear solution for k2 as in Feng's method. Estimatesof threeparameterswere generatedin this case as opposed to two when the input fi.mctionis measured. The same two part procedure was used to smooth the data as was -done with the DV and the graphical method was applied to the smoothed data using the reference region and an average efflux constant (Logan et al. 1996) .
Construction of Parametric Images
Reliable image wide parameter estimationmethods are importantbecause of the potential increased information content of parametricimages over ROI analysis, although both are important. One desirable characteristicof image wide parameterestimation methods is thatthey perform well in the presence of noise which is considerably greaterthan in ROIS. Other desirable characteristicsinclude speed of the calculation since it must be done for all voxels in the image, and model independence of the method since there will generally be variationsin specific binding so thatvoxels in one structuremay require a different model from voxels in another structure. The weighted least squaresmethod (Alpert et al. 1984; Koeppe et al. 1991) works well when a one compartment model is adequate for all regions. From this method parametric images of ligand transportrate and distributionvolume can be constructed. It requires a measured input fimction. Holthoff et al. (1991) have shown that alteringblood flow does not alterthe DV and thus demonstratedthatthe DV obtained in this manner is a measure of specific binding and not ligand transport.
Graphical analysis with a measured plasma input fiction (Logan et al. 1990 ) is model independentbut gives a biased estimatein the presence of significant noise particularly for ligands with high DV'S. However, Koeppe et al. (1997) . The method was found to work well for [llC] raclopride and [llC] CFT. The presence of additionalbinding in the reference region was tested by simulations and found to underestimatethe BP as expected. The graphical method with a reference region input (Logan et al. 1996 ) is model independentbut is subject to bias in the presence of noise. The previously described adaptationof the simplified reference tissue method used as a smoothing technique prior to applying the graphical analysis has been proposed as a possible solution to the bias problem.
The nonlinear least squares methods which are based on a particularmodel structuregenerally require considerable computation time as well as being subject to local minima. These methods are not generally used for image wide parameterestimation of DV or BP. The simplicity of the bolus plus constant infision equilibrium method makes it an attractivealternativealthough different structuresmay require different infusion schedules to achieve equilibrium. Jnthis case the method could be used for estimation of BP in voxels within a given structure.
For irreversible ligands parametric images of the influx constant Ki can easily be constructed (Patlkak et al. 1983 (Patlkak et al. , 1985 . However, since Ki depends upon blood flow comparisons based on this parameterwill be subject to differences in blood flow as well as changes in receptor binding.
If changes in transportare lmown to be important,then the transportconstant needs to be estimated. Logan et al (2000b) have proposed a method for estimatingK1 from initial part of uptake curve and using Ki to estimatehk3. .
Turkheimeret al. (2000) has introduced a new approach to generatingparametric images thatis based on a wavelet transform of each image in a dynamic sequence. Linear modeling procedures such as the graphical analyses can be done on the wavelet coefficients which represent a spatial object as opposed to a single pixel. This is followed by thresholding and the application of the inverse wavelet transform to recover the parametric image. Among the exiunples presented were dynamic PET FDG and [1lC] raclopride studies with the resultthat noise was reduced compared to graphical analyseswithout the wavelet transform while details of brain structureswere preserved. . .
Summary
A description of some of the methods used in neuroreceptor imaging to distinguish changes in receptor availability has been presented in this chapter. It is necessary to look beyond regional uptake of the tracer since uptake generally is affected by factors other than the number of receptors for which the tracer has affinity. An exception is the in.fhsionmethod producing an equilibrium state. The techniques vary in complexity some requiring arterialblood measurementsof unmetabolized tracer and multiple time uptake data. Others require only a few plasma and uptake measurements and those based on a reference region require no plasma measurements. We have outlined some of the limitations of the different methods. Laruelle . . .
Figure Captions:
Figure 1: Simulated data comparing two ligands with the same DV (DV=60 mL/mL) but different kinetics. The uptake is illustratedin a. The upper curve (~)has K1=0.5 mL/min/mL and L=l O.mL/mL with k3=0.1 rein-l and~=.02 rein-l (k3/ lQ=5). The lower curve (0) has K1=.6, L=3, k3=.1 and &=.005 (k3/~=20). The graphical analysis is illustratedin b, t*=35 min for o) and 80 min for (0). 
